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Abstract
Human olfactory receptor, hOR17-210, is identified as a pseudogene in the human 
genome. Experimental data has shown however, that the gene product of cloned hOR17-
210 cDNA was able to bind an odorant-binding protein and is narrowly tuned for 
excitation by cyclic ketones. Supported by experimental results, we used the 
bioinformatics methods of sequence analysis, computational protein modeling and 
docking, to show that functionality in this receptor is retained due to sequence-structure 
features not previously observed in mammalian ORs. This receptor does not possess the 
first two transmembrane helical domains (of seven typically seen in GPCRs).  It however, 
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possesses an additional TM that has not been observed in other human olfactory 
receptors.  By incorporating these novel structural features, we created two putative 
models for this receptor. We also docked odor ligands that were experimentally shown to 
bind hOR17-210 model. We show how and why structural modifications of OR17-210 do 
not hinder this receptor’s functionality. Our studies reveal that novel gene rearrangement 
that result in sequence and structural diversity in has a bearing on OR and GPCR function 
and evolution. 
Keywords: Olfactory receptors, functional pseudogene, computational modeling, 
docking.
Introduction 
GTP-binding Protein Coupled Receptors (GPCRs) are proteins that traduce the cell 
membrane and are responsible for catalyzing or initiating a cellular response in the form 
of a signal transduction process following an extracellular stimulus.1,2  GPCR function is 
wide and varied.  GPCRs are ubiquitously found in mammals, plants and fungi.3
Olfactory receptors (OR) constitute the largest gene families in mammalian genomes4.
Structurally, these entities are believed to be rhodopsin-like GPCRs, characterized by 
seven transmembrane helical regions that are connected by three extracellular and three 
intracellular loops, an extracellular N-terminus and an intracellular C-terminus.  Earlier 
experimental observations have shown that there exists a many-many binding/activating 
relationship between ORs and odors.  One odor may bind and activate more than one OR, 
while an OR might be activated by more than one odor.4-15 Olfactory receptors’ (OR) 
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interactions with odorous ligands are widely accepted as the first specific step in the early 
events leading to olfactory perception. Research has also suggested that interaction of 
odorant ligands with the binding region of an OR16,17 may cause the receptor to evolve 
from a structurally inactive to active state.  The olfactory system can differentiate 
odorous molecules based on structural and chemical diversity and concentration. 
  After the publication of the first draft of the human genome, several groups, 
working independently, identified the human olfactory repertoire18-21. As other 
mammalian genomes became available, the OR repertoires of these species were also 
identified22-24.  These genomic OR genes were identified as either putatively functional or 
non-functional and pseudogenic.  Initially, more than 60% of the human olfactory 
receptor genes were flagged as pseudogenes, while that number for the mouse OR 
repertoire stands at less than a third.22,23  As additional analysis is being carried out, the 
number of mammalian functional receptors however, is being constantly revised.25,26
There is evidence that primate evolution is marked by loss of olfactory functionality, as 
evidenced by a greater percentage of functional ORs in the evolutionary parent than the 
daughter.27
OR gene, hOR17-210 was genomically identified as pseudogenic (OR1E3P in the 
HUGO and HORDE (Human Olfactory Receptor Database Exploratorium house at 
http://bioportal.weizmann.ac.il/HORDE/) databases. This genomic pseudogene sequence 
was identified earlier as possessing a two-nucleotide frame shift28.  A cDNA clone of this 
frame-shifted sequence was subsequently shown to successfully initiate a G-protein 
mediated signal transduction cascade in the presence of a mixture of odorants (especially 
ketone compounds29) commonly perceived by humans.  
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We used bioinformatics strategies to show that this receptor protein has sequence-
structure features that are atypical of previously studied ORs or GPCRs. Despite these 
differences, this receptor remains functional. The novel sequence-structural features are: 
1) hOR17-210 has only six transmembrane helical regions (TMs) instead of the typical 
seven.  The first two TMs typically observed in models of ORs and GPCRs are missing.  
2) While this presumably reduces the number of TMs to five, there exists an additional 
TM, which occurs after what is typically observed as the C-terminus in other ORs. The 
sequence for this TM is only found in two other ORs—a chimpanzee and a cow homolog, 
which themselves have additional unique structural features.  4) The amino acid sequence 
motifs for ORs that have been implicated in G-protein coupling and olfactory sensory 
neurons targeting30, however, remain structurally and sequentially conserved. 5) Unlike 
mammalian ORs and GPCRs studied to date, the C-terminus is predicted to be 
extracellular.  
We show how and why these structural modifications may not hinder the function 
of this OR. We created two putative computational models of this receptor. Our models 
incorporate the novel sequence-structural features for this OR.  We also carried out 
computational docking studies using the preferred of the two models with selected odor 
ligands that are known to experimentally excite hOR17-210.29
Materials and Methods 
Sequence Analysis and Transmembrane Domain Prediction 
x Figure 1a shows the results of a comparative sequence analysis between the 
cDNA sequence functionally studied and the pseudogene (OR1E3P) identified 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
07
.1
29
0.
1 
: P
os
te
d 
2 
No
v 
20
07
from the genome in the HORDE database31. The former is listed in GENBANK 
(http://www.ncbi.nih.gov/) under Accession Number AAC99555, the latter, 
Accession Number U53583.  OR1E3P has a nucleotide sequence in a missing 5’ 
region located upstream from the cloned cDNA sequence.  The missing region is 
as follows: 
ATGATGAAGA AGAACCAAAC CATGATCTCA GAGTTCCTGC 
TCCTGGGCCT TCCATCCAAC CTGAGCAGCA GAATCTGTTC 
TATGCCTTGT TCTTGGCCGT GTATCTTACC ACCCTCCTGG 
GGAACCTCCT CGTCATTGTC CTCATTCGAC TGGACTCCCA 
CCTCCAC.
On the other hand, the sequence used in our informatics-based work and which 
was shown to be functional possesses the following additional base pairs at the 3’ 
terminus. 
TAGTAGGTGTAGTAAAGTTGATAATGAAATATCACTCTAAA
TCAGTGG CTTAA
x When the genomic gene sequences is translated using the TRANSLATE tool 
available through Swissprot’s Expasy web site 
(http://ca.expasy.org/tools/dna.html), OR1E3P (genomic OR17-210) contained 
several stop codons (denoted by /) after the first 132 residues. (Figure 1b) The 
TRANSLATE program also translates a given nucleotide sequence in three 
frames. A two-nucleotide frame shift yielded the same peptide sequence as 
AAC99555. The sequence in entry AAC99555, when directly translated yields the 
functional OR.  The bolded region in Figure 1c shows the cDNA cloned protein 
sequence that was used in our analysis and in the experimental functional studies 
29.
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x As a prelude to creating our computational model, we used Hidden Markov 
Models to predict transmembrane helices in hOR17-210. Figure 2 highlights 
regions that are predicted as TMs by two transmembrane prediction algorithms: 
TMHMM 32 and HMMTOP 33 TM.  Both were identified as the best D-helical TM 
prediction programs in an analysis of over ten such programs 34.   The figure 
shows that both programs agree in their identification of only six TMs and an 
extracellular C-terminus (red circles). 
x We carried out a sequence comparison of hOR17-210 with rat OR I7, Olr266 in 
Genbank (Accession Number P23270, Figure 3). OR I7, having been among the 
first cloned and identified ORs is also exceptionally well characterized, both 
experimentally 35 and computationally, structurally 36,37.   We use rat I7 here to 
represent ORs with structural features that are typical of GPCRs. The I7 TM 
regions are highlighted as predicted by both TMHMM and HMMTOP.  The 
figure shows that I7 has TM1 and 2. Both of these TMs are missing in hOR17-
210; the latter has an additional predicted TM after the C-terminus.  We denote 
this additional TM as TM7’.  Interestingly, the region of TM2 correctly predicted 
as a helical TM region for rat I7 is not predicted as a TM in hOR17-210 despite 
the apparent sequence similarities.  Experiments showed that this region was 
indeed extracellular and not a TM 29.
x We carried out a comprehensive BLAST search for hOR17-210 against 
GENBANK.  Sequence identity was found between hOR17-210 and its predicted 
chimpanzee and cow (Olr466) OR homologs.  Figure 4 shows the results of the 
alignment. The TM regions are highlighted.  All three sequences possess the 
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TM7’ region. The notable difference between the three sequences is that the 
predicted chimpanzee and cow homologs lack OR17-210’s frame shift mutation 
and so have seven intact TMs.  And just as in hOR17-210, the cow and 
chimpanzee homologs are missing the typically observed TM2. 
Constructing a structural model of hOR17-210 
We created two computational, structural models of hOR17-210 (Figure 5a and 5b). Our 
modeling strategies incorporated the new structural features discussed above. In addition 
to using homology modeling strategies 38 to create our preliminary model, we tested a 
new paradigm for rationalizing the hydrophobic nature of the inside of the receptor 
(Equation 1).  Since the first two TMs were missing, during homology modeling, the first 
five TMs of hOR17-210 were positioned in the helical assembly in orientations occupied 
by TMs 3, 4, 5, 6 and 7, respectively, in typical ORs. The key challenge however, was the 
location of orphaned region, TM 7’ which could be packed in either of the spaces 
formerly having been occupied by TM 1 or 2. 
• TM helical regions were predicted by using Hidden Markov Models through the 
programs: TMHMM2.0 39 and HMMTOP2.0 33.
• Due to the missing TMs 1 and 2 and the addition of an orphaned TM7’, the 
secondary structures of helices in positions 3, 4, 5, 6 and 7 were refined by 
alignment of the first five regions of hOR17-210 against the previously predicted 
secondary structure of rat OR-I7.  Each predicted OR helix was aligned to the 
center of the homologous helix in the rhodopsin structure, with no gaps. Two 
variants of helical packing were explored: in the first variant, the final orphaned 
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helix of hOR17-210 was aligned against helix 2 in rhodopsin; in the second 
variant, the last (orphaned) helix of hOR17-210 was aligned against helix 1 in 
rhodopsin.
• 3D models were generated using the homology modeling program, Modeler 8v2 
38.  We used the highest resolution structure (2.2 Å) of dark-adapted bovine 
rhodopsin 40 (Protein Data Bank ID: 1U19) as a template.  For the helical 
construction, each predicted OR helix was sequentially aligned to the center of the 
homologous helix in the rhodopsin structure, with no gaps. Two variants of 
helical packing were explored: in the first variant, the final orphaned helix of 
hOR17-210 was aligned against helix 2 in rhodopsin; in the second variant, the 
last (orphaned) helix of hOR17-210 was aligned against helix 1 in rhodopsin.
• Each helix of each variant of the structural model was minimized with typical D-
helix H-bond distance constraints using the consistent valence force field (CVFF) 
and conjugate gradient algorithm in Accelrys Discover suite of programs 
(http://www.accelrys.com/products/insight/). The helices were individually 
submerged in water during the energy minimization step to relax helical features 
specific to rhodopsin. 
• The hydrophobic moments at each residue around a helix were calculated using 
the following expression:  
i
oi
cos.
360
¦

 
 4
T
TT P    Equation [1] 
where, PTis the effective aggregate hydrophobicity at each point around a helical 
wheel computed by summing the arc contributions to the hydrophobicity moment 
on that residue from all other points along the helical wheel for a  given TM.   In 
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order to establish the correct frame of reference with respect to the entire helical 
assembly for hydrophobic moments derived from this algorithm, these were 
initially calculated for the TMs in rhodopsin and subsequently mapped to the 
actual rotational orientations within the helical bundle.  We observed that in 
rhodopsin, that the largest 4 valued residues in TM 1, 3, 4, and 7 pointed toward 
the binding pocket; for TM2, the largest 4 pointed away from the binding region; 
and for TMs 5 and 6, the largest aggregate hydrophobic moments pointed toward 
each other. The hydrophobicities for hOR17-210 were computed and the TM 
helices were rotated and oriented using this rationale.
• After helix construction and rotation, the helices were used as the input template 
into the Modeller software for ab initio assignment of the intra- and extracellular 
loop residues. The resulting structure was then rigorously minimized using the 
Accelrys Discover program by constraining only the motion of the alpha-carbon 
atoms of the protein in order to maintain the integrity of the transmembrane 
helices.
 Of the two models created, our preferred model is one where TM7’ is positioned 
in place of TM2.  As shown in figure 4, the protein sequences in the chimpanzee and cow 
homologs both have strongly predicted TM1s and therefore, in order to maintain the 
helical bundle, TM7’ would have to be placed in the position typically occupied by TM2. 
Ligand docking 
We docked eight ligands: beta -ionone, d- and l-camphor, 2- and 6-undecanone, heptanal, 
decanal, nonanol and nonanone (ligand positional parameters and those for the two model 
variants are available from corresponding author) in the binding pocket of our preferred 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
07
.1
29
0.
1 
: P
os
te
d 
2 
No
v 
20
07
model of hOR17-210—with the TM7’ homology-modeled in the place of missing TM2 
Figures 6a (ringed ligands) and 6b (straight chain ligands) show the results of 
computational docking.   Of these ligands, experimentally, the cyclic ketones show strong 
responses, the straight chain ketones show weak responses and the alcohols show no 
response at any concentration. (Personal Communications—CR). These docked ligands 
vary in length of carbon chain and functional groups (aldehyde, ketone, alcohol and ring 
structures). Ligand models were constructed using the InsightII suite of software 
(http://www.accelrys.com/insight/).
Ligand conformational energies were minimized using the Discover module in 
InsightII.  We added hydrogen atoms to our I7 OR model 36 to create a system of pH 7.0.  
Atomic charges were assigned using Consistent Valence Force Field (CVFF).  We used 
DOCK 41,42 to identify the ideal binding configurations of the ligands in the binding 
pocket 36 of the 17-210 human olfactory receptor model.  Using every atom in the OR 
model as input for the DMS (Dot Molecular Surface) program 43, we calculated a solvent 
accessible molecular surface-area for the I7 model; and,  DOCK’s SPHGEN (SPHere
GENerator) module identified cavity site-points in the receptor.  We discarded spheres 
that represented cavities on the intracellular side of the receptor; these spheres were 
structurally “below” the TM3 and TM4 crossover plane in the model.  The GRID module 
in DOCK was used to generate force fields and interaction parameters to compute 
intermolecular binding. DOCK used spheres that were retained to compute spatial 
restraints based on van der Waals interactions. Flexible_Ligand, a module in DOCK, 
allowed the modification of torsion angles in the ligand. Figures 6a and 6b show the 
docked ligands in the receptor model. 
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Results
The helical regions and the internal and external locations of the intra and extracellular 
loops and the N- and C-termini are highlighted in the figure 3, which compares the 
sequences of hOR17-210 and rat OR I7, one of the first ORs cloned 44, functionally 
analyzed 35, and modeled 36,37.  The highlighted regions in the I7 sequence in figure 3 are 
representative of what is typically known about ORs.  Figure 2 shows that both 
HMMTOP and TMHMM transmembrane prediction programs agree that for hOR17-210: 
1) the region beginning with PMY-- is not a TM, although it is predicted to be  the 
second TM in most ORs; 2) the region we identify as the orphaned TM, TM 7’ exists; 
and, 3) the C-terminus of the receptor must be atypically extracellular.   TM 7’ in OR17-
210 extends past the C-terminus of ORI7. The amino acids of the C-terminus in I7 and 
the final intracellular loop (between TM 7 and 7’) of OR17-210 are conserved. 
The hOR17-210 sequence begins with a MPMY polypeptide region.  Typically, 
in ORs, the PMY sequence motif marks the beginning of TM 2.  HMMs for this 
functional hOR17-210 sequence predict however, that the region beginning with PMY 
(i.e., MPMYLCLSNLSFSDLCFSSVTM is not a helical TM and is extracellular). 
Experimentally, heterologous expression of a FLAG (DYKDDDDK polypeptide 
sequence) tagged receptor in insect cells confirmed an extracellular N-terminus 29.  This 
leads us to conclude that hOR17-210 is missing both the first and second TMs when 
compared to other mammalian ORs.  The hOR17-210 transmembrane regions start from 
what would typically be TM3 in other ORs.  The “MAYDRY” motif region, a highly 
conserved sequence within Class A GPCRs and known to be located at the intracellular 
end of this TM, has been shown to be essential for G-protein coupling and the initiation 
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of signal transduction following ligand-binding 30,45,46. In the case of hOR17-210, the 
“MAYDRY” sequence has undergone mutation to MAYHCY; since this TM must be 
oriented extracellular to intracellular in order for correct positioning of this conserved 
motif, it allows the polarity of the remaining TMs predicted by the HMM to be 
determined with certainty. 
A sequence similarity search of the TM 7’ peptide region 
“FVFKIVIVGILPLLNLVGVVKLI,” returns only two matches.  The first is a 
chimpanzee OR (GENBANK Accession Number XP_523775), which is homologous to 
hOR17-210; the second is a cow OR (GENBANK Accession Number XP_872923). 
HMM of these OR sequences predicts that, in addition to the presence of TM 7’, the 
polypeptide regions beginning with PMY are also not TM helices.  One major difference 
is that these two orthologs do, however, possess intact TM 1 helices. (Figure 4)
The constrained polarity of the final TM (TM 7’) causes the C-terminus of OR17-
210 to become extracellular. Extracellular C-termini have been predicted in Drosophila 
odorant receptors.47 The sequence region RNRDMRGNPGQSLQHKENFF is the third 
intracellular loop in hOR17-210 (between TM 7 and TM 7’).  We carried out a BLAST 
search using the above sequence of this loop, focusing the search to return only 
sequences for olfactory receptors. From over 2500 results, the “RNRDMRG” region is 
strongly conserved (greater than 70% identify and 100% positive matches, where R is 
often replaced by K) in the C-termini of most ORs (and is possibly involved in GPCR-G-
protein interactions).  hOR17-210 functionality is therefore, not affected by an extra-
cellular C-terminus or the lack of a TM (the absence of TMs 1 and 2). 
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Figures 6a and 6b indicate that all the docked odorous ligands are clustered in the 
same spatial region bound by the first four TMs (3, 4, 5 and 6) of hOR17-210.  The 
numbers in parenthesis indicate the TM numbers for typical ORs.  An inspection of the 
interior of the receptor, which is modeled using the hydrophobicities determined using 
equation [1] indicate that there are no strongly polar residues pointing into the binding 
pocket, except His48 on TM1.  This residue however, is greater than 10Å away from the 
nearest ligand atom.  The nearest distances from every side-chain atom within the 
receptor’s binding pocket to each atom of the docked ligands were calculated.  The 
closest distance (between 0.8 and 1.5 Å) was for Ala108, specifically between ligand 
atoms and the methyl hydrogens in Ala108.  Some of the interactions can be considered 
to be electrostatic in nature because they are between the ligand carbonyl oxygen and the 
Ala108 hydrogen atoms.  Possible interactive distances were also observed between 
ligands and Phe122 and Cys123.  These residues however, belong to the first 
extracellular loop, which in our model dips into the binding pocket. The contributions of 
these residues however, cannot be ascertained because of the dynamic nature of loop 
conformations.  
Discussion
We created computational structural models for two possible variants to account 
for the atypical nature of the hOR17-210 (Figures 5a and 5b).  Such a model, based on 
structural template  matching (the sequence homology between I7 and rhodopsin is less 
than 40%) 10,14 may however, introduce rhodopsin structure-specific biases into the 
model.  Biases include differences in lengths of loops 48 and kinks 49,50 in TM helical 
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domains.  We attempted to limit the intra-helical biases by allowing each helix to 
structure-energetically relax in an aqueous medium individually before assembling the 
TM domains.   
The first step in any GPCR modeling study is the identification of the TM 
regions.  TM helices presumably protect the interior of the binding pocket from the 
surrounding lipid bilayer, while at the same time, ensuring that the signal-transducing 
structural features of the receptor are properly positioned inside and outside the cell. 
We aligned the first five TMs of hOR17-210 cloned sequence in the positions occupied 
by TMs 3, 4, 5, 6 and 7 of typical ORs, respectively.  In each variant, TM 7’ occupied the 
positions typically occupied by TM 1 and TM2, respectively. Our modeling strategy 
ensured that sequentially conserved (and possibly functionally implicated) regions were 
positioned as found in typical ORs. TM 7’ in the two variants was positioned to maintain 
the structural integrity of the TM scaffold while protecting the interior of the OR and the 
odor ligand.  We have indicated earlier that orthologs of hOR17-210 exist in cow and 
chimpanzee. Evidence of sequence predicted as TM7’ and absence of TM2 in observed in 
only these three mammalian ORs. During hOR17-210 modeling, when presented with a 
choice of positioning TM7’ in the position of TM1 or TM2, we posit that since the cow 
and chimpanzee orthologs retained TM1 and were missing only the typical TM2, the 
orphaned TM7’ would favorably occupy in the position of TM2. (Figure 5b). For
olfactory function to persist, the main GPCR scaffold needs to be maintained.  
Katada et al. 51 have shown that the C-termini of ORs are involved in G-protein 
interactions.  Our BLAST results have shown that the third intra-cellular loop shows 
strong sequence homology with several hundred vertebrate ORs, especially in the 
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“RNRDMRG” sequence motif, which is invariably in the C-terminus, specifically, in the 
region where the seventh TM ends and the C-terminus begins.   A few of the more than 
900 results also show homology in the rest of this intra-cellular loop and the homolgous 
ORs are always in the C-terminus.  This indicates to us that if a certain motif of amino 
acids interacts with the G-protein, then this motif is present in OR17-210 intracellularly.  
We conclude therefore that OR function is not hindered because of the presence of an 
intracellular third loop. 
An extracellular C-terminus for mammalian ORs has also not been experimentally 
shown.  The presence of an orphaned TM puts the C-terminus extracellularly.  This is 
confirmed by two TM prediction programs.  Experiments involving the attachment of a 
poly-Histidine tag to the end of the OR would confirm the extracellular C-terminus for 
hOR17-210.
Identifying the active and inactive states for an OR and elucidating its role in 
olfaction at a molecular level necessitates an experimental determination of its protein 
structure, in addition to knowledge of its odorant repertoire.  There is currently, no 
experimentally derived structure of an olfactory receptor.  This lack of a structure 
engenders the assumption that GPCRs are structurally similar to rhodopsin.  Every 
computational study of olfactory receptors and other GPCRs uses a rhodopsin structure 
(the x-ray derived structure with the highest resolution 40 as used in our modeling here or 
a lower resolution electron diffraction structure 52).  Modifications to remove rhodopsin-
specific biases as detailed in the Materials and Methods section begin from this point. 
Computational modeling, docking and simulation studies 15,36,37,53 have shown 
that the OR binding region is on the extracellular side—a pocket that is created by side 
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chains belonging to TM regions 3, 4 5 and 6—which is confirmed by our docking results.  
Our docking results indicate that the ALA108 is the only residue in the binding pocket 
that is within Van der Waals distances with the ligands.  These docking results are 
preliminary at best. Since all the odors docked in the same general area of the binding 
region, we believe that the binding region is apt for odor-OR interactions.  We have 
previously shown that dynamic simulation of odorous molecules in the olfactory receptor 
binding pocket provide instances of interactions with key amino acid residues in the 
binding pocket.  These interactions are however, not always observed as a result of static 
docking.  The time and computational effort required to complete the dynamic simulation 
of all odors identified that excite hOR17-210 strongly make it the subject of another 
paper.   Certainly, site-directed mutagenesis results would provide us with better starting 
points in our docking and simulation studies.  These results unfortunately, do not exist for 
this receptor. 
Our standard model building protocols differ slightly from those previously 
established 36,53,54, by independently predicting the TM regions followed by removing of 
rhodopsin structure specific biases.  In the case of hOR17-210, we are breaking new 
ground because we have identified and attempt to model a novel TM (TM 7’) that has not 
been sequence-structurally observed. Once TM 7’ was placed in position of TM2 (our 
preferred structure), it was subject to the same TM-modeling protocol as other TMs in 
our model. Further validation of the novel method we introduced with equation [1] of 
calculating hydrophobic moments for determining TM rotations would also be aided by 
future experimental work followed by fine tuning of our modeling strategies. 
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 Future work with experimental functional analyses following key point mutations 
would aid in identifying the role of binding pocket residues in ligand interactions.
Simulating the dynamic motion of ligand in the OR binding pocket where its interactions 
with key residues in the binding pocket can vary over the time period of the simulation 
would be useful to identify if other residues are involved in the ligand-OR interaction.
Also, computational docking shows that ligands tested (Figures 6a-b) are clustered within 
a single region, we can only surmise from the docking results that this region is the 
preferred binding region for this OR..
Conclusion
This informatics-based study, supported by experimental results, identifies an OR 
possessing atypical sequence-structure features while still maintaining olfactory 
functionality.  The human olfactory repertoire reveals that the ratio of functional ORs to 
pseudogenes is 1:2 (http://senselab.med.yale.edu/senselab/ORDB/humanOR.html).  This 
number has been revised more recently and will be likely revised as more information 
becomes available and more genome level experiments are carried out. 
Evolutionarily, hOR17-210 could occupy a position of transition between 
functional and pseudogenic ORs.  This receptor is a possible illustration of how loss in 
OR function may occur, namely, through mutations that create unfavorable sequences for 
transmembrane helical assembly. Our study, we hope, will cause researchers to reassess 
the sequence-structure-function correlates in olfactory receptors, and also the necessity to 
incorporate structural features in the classification of ORs and GPCRs. 
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We have used bioinformatics methods to show how and why a receptor appearing 
pseudogenic in several portions of the population can be functional in others.  
Functionality was confirmed by measuring the experimental, varying excitatory 
responses to odor ligands with different of functional groups.  While hOR17-210 appears 
to lack the first two TMs typically observed in ORs,  it possesses an additional TM 
present in only two other non-human olfactory receptors in all of GenBank.  This TM, 
named TM 7’, may preserve olfactory function within this OR (when functional) by 
maintaining the TM structure, thus protecting the binding odor ligand.  The intracellular 
positions of regions identified as possibly responsible for olfactory function, due to their 
highly conserved nature, are preserved. hOR17-210 possibly straddles the point in 
mammalian OR evolution where loss of function occurs. 
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List of Figures 
1a) Results of the sequence alignment between OR17-210 cDNA found in GENBANK 
Accession number (AAC99555) and OR1e3P genomic DNA found in the HORDE 
database.  The functional region in OR17-210 begins from nucleotide 170.  This is caused 
by a two-residue frame shift in the genomic DNA.  The sequence of the functional 
protein also contains an added region beginning from nucleotide number 977.  This 
orphan TM 7’ and the extracellular C-termini are contained in this region.  The frame 
shift results in a stop codon beyond nucleotide 1030. 
1b)  Results of the translation of the genomic DNA for Or1e3P as found in the HORDE 
database.  The presence of stop codons indicates that the receptor is pseudogenic as 
listed.
1c) Results of the translation of the genomic DNA of OR1e3P as found in the HORDE 
database, but following a 2-nucleotide frame shift.  This sequence is however, is missing 
the 3’ region that resulted in the orphan TM observed in ACC99555 (the sequence used 
in the functional studies). 
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2. Figure shows the results of Hidden Markov Model predictions of termini, intra and 
extra-cellular loops in hOR17-210.  Two different profiling programs were used, 
TMHMM and HMMTOP.  The yellow highlighted regions show the predicted TM 
helices.  The blue colored regions indicate the extra-cellular N-termini which contains 
MPMY polypeptide motif, which marks the beginning of TM2 in most ORs.  The region 
last highlighted region is the orphan TM 7’ region.  The red colored region shows that the 
C-terminus of this protein is extracellular. 
3. Figure shows the results of a sequence alignment with rat I7, here represented as a 
typical olfactory receptor, and hOR17-210. The highlighted regions indicating the TM 
domains assigned to the model show that 17-210 lacks TMs 1 and 2, that the MPMY 
region is extracellular.  It shows alignment between TM1 of hOR17-210 and I7, with the 
HCY of OR17-210 and the DRY of I7 aligned in the intracellular loop.  The figure also 
shows strong alignment between the third intracellular loop of OR17-210 and the C-
terminus of I7, before the origination of TM 7’ in OR17-210. Yellow segments show 
final TM helical assignments used in the models.
4. Figure shows the results of sequence alignment of hOR17-210, its predicted 
chimpanzee homolog and predicted OR in cow (Orl466-homolog). Each OR shows 
atypical features of the polypeptide region beginning with PMY not being a TM, and the 
existence of a TM 7’.  Additionally, the chimpanzee and the cow OR gene products show 
the existence of a TM 1. Residues highlighted in yellow are regions predicted by 
TMHMM to be transmembrane domains. 
5a: Figure shows a structural model for OR17-210 with the TM 7’ occupying the position 
typically occupied by TM 1 in rhodopsin-like GPCRs. 
5b: Figure shows a structural model for OR17-210 with the TM 7’ occupying the position 
typically occupied by TM 2 in rhodopsin-like GPCRs.  
6a: Figure shows the docking of three ligands with ring structures: beta ionone (green), 
D-camphor (yellow) and L-camphor (pink).  The figure shows the proximity of the 
docked ligands to ALA108 in white.  The binding is expectedly in the region bound by 
TMs 3 (1), 4 (2), 5(3) and 6(4).  The TM identifiers are numbers typical of ORs and 
GPCRs.  The numbers in parentheses are TM numbers for hOR17-210. 
6b:  Figure shows the docking of five ligands straight chains: decanol (yellow), 
nonanone(green), nonanol (pink), 2-undecanone (orange) and 6-undecanone (white).  The 
figure shows the proximity of the docked ligands to ALA108 in white.  The binding is 
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expectedly in the region bound by TMs 3 (1), 4 (2), 5(3) and 6(4).  The TM identifiers are 
numbers typical of ORs and GPCRs.  The numbers in parentheses are TM numbers for 
hOR17-210.
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